Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients

Intravenous immunoglobulin (IVIg) is used in the therapy of various autoimmune and inflammatory diseases. Recent studies in experimental models propose that anti-inflammatory effects of IVIg are mainly mediated by α2,6-sialylated Fc fragments. These reports further suggest that α2,6-sialylated Fc fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Meenu, Schoindre, Yoland, Hegde, Pushpa, Saha, Chaitrali, Maddur, Mohan S., Stephen-Victor, Emmanuel, Gilardin, Laurent, Lecerf, Maxime, Bruneval, Patrick, Mouthon, Luc, Benveniste, Olivier, Kaveri, Srini V., Bayry, Jagadeesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375975/
https://www.ncbi.nlm.nih.gov/pubmed/25012067
http://dx.doi.org/10.1038/srep05672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375975/
https://www.ncbi.nlm.nih.gov/pubmed/25012067
http://dx.doi.org/10.1038/srep05672

Ejemplares similares